CLYDPharmaceutical PreparationsFiscal year ends December 31
BEACON TOPCO, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 14, 2026
Share price
Not available yet
Price, market cap and P/E appear here once daily prices are connected.
Earnings
Quarterly results announced on Form 8-K, Item 2.02
No earnings releases found
Beacon Topco has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.
Press releases
Announcements Beacon Topco filed with the SEC
Results from a Phase 1b Study of Balomenib in Type 2 Diabetes Patients, Showing Glycemic Improvement Sustained for Three Months After
Material agreement · Other events · EX-99.1 to Form 8-K